Prostate Cancer Treatment in China: Methods, Hospitals and When Travel Is Unnecessary

Prostate cancer care in China for international patients: surveillance vs surgery vs radiation (including selected proton), systemic therapy for advanced disease, named centres, and when a China trip adds nothing over local urology.

7500+

patients treated

10

years of experience

50+

partner clinics

Prostate: three bills, and sometimes no trip

Risk / goalChina trip?Desk / cost note
Low-risk localisedOften noLocal surveillance or straightforward treatment at home
Intermediate / high-risk local therapyIf you need volume or a second methodFudan, CAMS/NCC, Ruijin — surgery vs IMRT, not one SKU
Selected protonOnly if geometry + imagingSPHIC / Ruijin; ~USD 20-35k + 4-7 hotel weeks
Metastatic / after ADTOnly for a systemic gap at homeDrug calendar (ARPI/chemo) often dwarfs travel
Prostate CAR-T adNo as standardTrial claim until named

Cancer hub · Proton · Cost drivers · Hospitals

What the medical trip includes

  • 📋

    Risk group before a city

    PSA, Gleason/ISUP, MRI. Low-risk localised disease often does not justify the flight.

  • 🏥

    Urology vs radiation room

    Fudan, CAMS/NCC, Ruijin for most files. SPHIC only if particle therapy is the actual question.

  • ✈️

    Three different bills

    Operation, multi-week radiation/proton, or months of ADT/ARPI. We will not mash them into one package.

Why patients choose us

  • ✅

    We will say ‘stay home’

    If local urology already covers the risk group, we say so.

  • 💬

    Proton not sold as default

    IMRT remains appropriate for many prostate plans. Particle therapy is indication-gated.

  • 🌍

    Drug calendar visible

    Advanced disease is often a pharmacy problem. Hiding ARPI names hides the bill.

How it works

  • 01

    Send PSA, biopsy and MRI

    Prior radiation dose if re-treatment is the question.

  • 02

    Decide if China adds a method

    Surgery, photons, proton, or systemic sequencing — or no trip.

  • 03

    Travel only for that method

    Invitation and stay length follow prostatectomy vs a 5-7 week beam calendar.

Treatment package costs

  • Prostate file review

    No charge to start

    Risk-group read • Travel yes/no • Centre or SPHIC note • Cost-basket split

  • Coordinated trip

    Only if a method requires it

    Hospital matching • Stay calendar • Visa • Interpreter

Who this is for

  • Localised disease weighing surgery vs radiation

    Need a high-volume opinion, including when proton is not worth the extra weeks.

  • Biochemical recurrence or re-irradiation questions

    Need prior dose data and a centre that will plan, not a package.

  • Metastatic patients on or after ADT

    Need systemic sequencing and drug-cost honesty more than a tourist ward.

Frequently asked questions

  • What treatments are used for prostate cancer in China?

    Surveillance, prostatectomy, external radiation or brachytherapy, ADT and AR-pathway drugs, chemotherapy, and selected proton for defined geometries. The risk group picks the list.

  • Is travel always required?

    No. Many localised cases are handled well at home. A China review is useful when you need a specific technology, a second high-volume opinion, or advanced systemic options that are delayed locally.

  • Is proton therapy used for prostate cancer?

    At selected centres, for selected localised geometries — not automatically better than IMRT. SPHIC/Ruijin need planning imaging. See the proton page.

  • How much does it cost?

    Surgery and radiation are different baskets. Proton, if accepted, uses the USD 20,000-35,000 course band plus hotel weeks. Long ADT/ARPI drug costs can exceed both. No single prostate package.

  • Which hospitals?

    Fudan, CAMS/NCC, Ruijin; SPHIC when the question is a beam. Fuda is not a default prostate centre.

  • Is CAR-T used for prostate cancer?

    Not standard of care. Treat cell-therapy ads as trial claims until a named protocol exists.

  • What should I send?

    PSA trend, biopsy Gleason/ISUP, pelvic MRI, staging bone or PSMA scan if available, and any prior radiation dose or ADT.

More about treatment in China

Prostate cancer treatment in China is worth a trip only when the file needs a specific department: complex local therapy, a radiation/proton geometry, or advanced systemic sequencing that is slow or costly at home. Low-risk localised disease is often active surveillance or straightforward local treatment; flying to China is frequently unnecessary. Intermediate and high-risk localised disease may involve prostatectomy or modern radiation. Selected patients ask about proton — that is an indication and imaging question for SPHIC or Ruijin, not a default upgrade. Advanced and metastatic disease is largely a drug calendar (ADT, AR-pathway inhibitors, chemo, selected radioligand if available). Centres: Fudan, CAMS/NCC, Ruijin (urology plus proton programme), SPHIC for accepted particle cases. CAR-T is not a prostate standard. Fuda is not the default urology answer. Cost splits three ways: an operation and a short stay; a multi-week radiation or proton course (proton planning band about USD 20,000-35,000 if accepted); and months of systemic drugs that often dwarf both. There is no honest single prostate price. Send PSA history, biopsy Gleason/ISUP, MRI, bone or PSMA imaging if done, and prior ADT or radiation dose.
Home
Menu
Search
Инфо